FOPPOLI, MARCO
 Distribuzione geografica
Continente #
AS - Asia 808
EU - Europa 763
NA - Nord America 623
SA - Sud America 169
AF - Africa 13
Totale 2.376
Nazione #
US - Stati Uniti d'America 584
RU - Federazione Russa 521
SG - Singapore 299
CN - Cina 198
BR - Brasile 140
VN - Vietnam 97
BD - Bangladesh 80
HK - Hong Kong 77
SE - Svezia 61
IT - Italia 60
FR - Francia 40
GB - Regno Unito 24
CA - Canada 21
IN - India 15
DE - Germania 14
AR - Argentina 13
MX - Messico 12
PL - Polonia 11
CL - Cile 7
ES - Italia 6
FI - Finlandia 6
ID - Indonesia 5
TR - Turchia 5
IQ - Iraq 4
NL - Olanda 4
PK - Pakistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
EC - Ecuador 3
IE - Irlanda 3
IR - Iran 3
JP - Giappone 3
MD - Moldavia 3
UZ - Uzbekistan 3
VE - Venezuela 3
BY - Bielorussia 2
GT - Guatemala 2
KR - Corea 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
PY - Paraguay 2
TN - Tunisia 2
AZ - Azerbaigian 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MV - Maldive 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
SA - Arabia Saudita 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 2.376
Città #
Singapore 165
Dallas 136
Moscow 111
Ashburn 91
Hong Kong 77
San Jose 54
Ho Chi Minh City 44
Beijing 38
Shanghai 29
Hefei 24
Lauterbourg 24
New York 24
Los Angeles 21
Orem 21
Hanoi 20
São Paulo 19
Lawrence 18
Princeton 18
Santa Clara 18
Milan 13
Rome 11
Warsaw 10
Houston 9
Chennai 8
Denver 8
Montreal 8
Poplar 8
Brooklyn 7
Frankfurt am Main 7
London 7
Buffalo 6
Mexico City 6
Stockholm 6
Atlanta 5
Chicago 5
Helsinki 5
Phoenix 5
Rio de Janeiro 5
San Bernardo 5
Amsterdam 4
Guangzhou 4
Johannesburg 4
Ankara 3
Biên Hòa 3
Boardman 3
Boston 3
Cesano Boscone 3
Dublin 3
Juneau 3
Memphis 3
Mumbai 3
Naples 3
Niterói 3
Palhoça 3
Querétaro 3
Roubaix 3
Tashkent 3
The Dalles 3
Tokyo 3
Toronto 3
Vienna 3
Amparo 2
Andover 2
Asunción 2
Baghdad 2
Bắc Ninh 2
Calgary 2
Campinas 2
Carapicuíba 2
Catania 2
Chongqing 2
Concord 2
Goiânia 2
Haiphong 2
Istanbul 2
Las Vegas 2
Machala 2
Magé 2
Manchester 2
Minsk 2
Mogi das Cruzes 2
Munich 2
Ninh Bình 2
Nuremberg 2
Osasco 2
Ottawa 2
Pisa 2
Porto Alegre 2
Providence 2
Sharjah 2
Staten Island 2
Tianjin 2
Venice 2
Yerba Buena 2
Zola Predosa 2
Afragola 1
Akron 1
Ambāla 1
Americana 1
Angra dos Reis 1
Totale 1.238
Nome #
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 197
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial 150
Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review 127
Application of a Pharmacokinetic Model to Inform the Optimal Dose for Individualized Drug Administration 119
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 111
The impact of histopathologic diagnosis on the proper management of testis neoplasms 92
[Cardiac involvement by non-Hodgkin's lymphoma in an HIV-positive patient with hypertrophic obstructive cardiomyopathy]. FT Localizzazione cardiaca di linfoma non-Hodgkin in soggetto HIV positivo affetto da cardiomiopatia ipertrofica ostruttiva. 92
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation 91
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 89
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 88
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial 85
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 84
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma 82
Gamma-delta t-cell lymphomas 81
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas 80
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial 78
Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man 77
A minimal physiologically based pharmacokinetic model for high-dose methotrexate 77
Optimal dose and uncertainty estimation for individualized drug administration using pharmacokinetic models 74
Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure 68
Primary central nervous system lymphomas: Salvage treatment after failure to high-dose methotrexate 67
Development of a whole-body physiologically-based pharmacokinetic model for high-dose methotrexate 65
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES 58
Questions and answers in the management of primary central nervous system and ocular lymphomas 57
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era 51
Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma 46
The primary mediastinal lymphoma: State of the art and therapeutical perspectives 41
Treatment of primary central nervous systemlymphoma. Recent advances 40
Treatment approaches for primary CNS lymphomas 40
Totale 2.407
Categoria #
all - tutte 10.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 8 1 1 0 4 0 1 0 3
2022/202393 43 19 6 0 0 13 3 5 4 0 0 0
2023/202447 2 1 2 6 11 4 1 3 2 1 2 12
2024/2025288 30 4 2 12 22 34 36 16 43 28 15 46
2025/20261.948 86 123 205 288 213 46 109 138 451 72 68 149
Totale 2.407